ArtiQ
Company

Last deal

$1.13M
Local Amount - EUR 1M

Amount

Seed

Stage

15.07.2019

Date

1

all rounds

$1.13M

Total amount

date founded

Financing round

General

About Company
ArtiQ uses AI-based software to improve lung disease diagnosis and save doctors time.

Industry

Sector :

Subsector :

founded date

07.02.2019

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Founded in early 2019 by four experts in respiratory medicine, medical devices, and AI, ArtiQ aims to be the go-to partner for medical practitioners dealing with respiratory problems. Their software automates the interpretation of pulmonary function tests, giving probabilities of disease presence and recommendations for next steps. By assisting in early detection of disease patterns, ArtiQ's software improves the diagnostic process and helps healthcare professionals provide better care for their patients.
Contacts

Contact Email

Social url

Similar Companies
1000
Koios Medical

Koios Medical

Koios Medical uses AI algorithms to improve disease detection and diagnosis.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Artificial Intelligence, Health Diagnostics

Location

Chicago, IL, USA

total rounds

3

total raised

$143M
Diagu

Diagu

Digam is a medical technology company that uses AI and machine learning to diagnose diseases and suggest treatments.

Sector

Health Care Providers

Subsector

Health Care Services

Location

Poznań, Poland

total rounds

2

total raised

$4M
Aidence

Aidence

Aidence provides radiologists with a software platform that uses Deep Learning to automatically detect and classify various disorders.

Sector

Health Care Providers

Subsector

Health Care Services

Location

Amsterdam, Netherlands

total rounds

3

total raised

$13.99M
Onkolyze

Onkolyze

Onkolyze develops AI software for diagnosing medical conditions.

Sector

Health Care Providers

Subsector

Health Care Services

Location

Singapore

total rounds

1
M&A Details
1

Transaction name

Acquired by

Clario

announced date

02.04.2024

Financials

Funding Rounds
1
1

Number of Funding Rounds

$1.13M

Money Raised

Their latest funding was raised on 15.07.2019. Their latest investor KBC. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
15.07.2019
2
$1.13M
Local Amount - EUR 1M
KBC

KBC

KBC Private Equity provides development capital and buy-out financing to medium-sized companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Finance, Banking

Location

Brussels, Belgium

count Of Investments

21

count Of Exists

4
Gemma Frisius Fund

Gemma Frisius Fund

Gemma Frisius Fund: venture capital firm in Leuven, Belgium, providing seed/start-up capital.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Leuven, Belgium

count Of Investments

30

count Of Exists

4
Co-Investors
Investors
2
2

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Seed
KBC

KBC

KBC Private Equity provides development capital and buy-out financing to medium-sized companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Finance, Banking

Location

Brussels, Belgium

count Of Investments

21

count Of Exists

4
Gemma Frisius Fund

Gemma Frisius Fund

Gemma Frisius Fund: venture capital firm in Leuven, Belgium, providing seed/start-up capital.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Leuven, Belgium

count Of Investments

30

count Of Exists

4

People

Founders
1
Marko Topalovic
Marko Topalovic

Marko Topalovic

Marko Topalović, PhD is a CEO of ArtiQ (Leuven, Belgium), an artificial intelligence (AI)-based software company that aims to become the trusted partner of medical practitioners for diagnosis, treatment, and follow-up of respiratory problems. Prior to co-founding the ArtiQ (University spin-off), as a postdoctoral researcher in the University Hospital in Leuven, Marko worked on improving and developing machine learning algorithms for diagnosing lung diseases. Marko obtained a PhD degree on the topic “Artificial intelligence for pulmonary function tests” in the Laboratory for respiratory disease, at the prestigious KU Leuven (Belgium). With an MSc in Computer Sciences, he continually tries to connect two fields with a goal to augment healthcare using state-of-the-art technology. His scientific work has contributed to many peer-reviewed publications and numerous conference presentations. Moreover, he received international awards on several different occasions. Marko earned his business education from the Flanders Business School (Belgium).

current job

ArtiQ
ArtiQ

organization founded

1

Marko Topalovic

Employee Profiles
2
Hogne Ulla

Hogne Ulla

Business Development Manager

Marko Topalovic

Marko Topalovic

CEO

Activity

Recent News
1